Showing results (61-70 of 174) with videos related to
Sort By:
Pageof 18
Breast (Edinburgh, Scotland)|April 5, 2015
New approaches for improving outcomes in breast cancer in EuropeAngelo Di Leo, Giuseppe Curigliano, Véronique Diéras, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2 (HER2), and epidermal growth factor receptor expression and benefit from lapatinib in a randomized trial of paclitaxel with lapatinib or placebo as first-line treatment in HER2-negative or unknown metastatic breast cancerRichard S Finn, Michael F Press, Judy Dering, et al.Cancers|June 2, 2021
Circulating Biomarkers of CDK4/6 Inhibitors Response in Hormone Receptor Positive and HER2 Negative Breast CancerIlenia Migliaccio, Angela Leo, Francesca Galardi, et al.Molecular Oncology|December 26, 2014
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patientsMarta Pestrin, Francesca Salvianti, Francesca Galardi, et al.Breast Cancer (Tokyo, Japan)|May 13, 2019
A meta-analysis of clinical benefit rates for fulvestrant 500 mg vs. alternative endocrine therapies for hormone receptor-positive advanced breast cancerJohn F R Robertson, Zefei Jiang, Angelo Di Leo, et al.Anticancer Research|August 1, 2018
Platinum-based Agent and Fluorouracil in Metastatic Breast Cancer: A Retrospective Monocentric Study with a Review of the LiteratureLorenzo Rossi, Chiara Biagioni, Amelia McCartney, et al.Breast (Edinburgh, Scotland)|April 29, 2014
Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapyIvana Bozovic-Spasojevic, Lieveke Ameye, Marianne Paesmans, et al.Biomolecular Detection and Quantification|April 15, 2016
Feasibility of a workflow for the molecular characterization of single cells by next generation sequencingFrancesca Salvianti, Giada Rotunno, Francesca Galardi, et al.Breast Cancer Research and Treatment|July 15, 2009
Correlation of HER2 status between primary tumors and corresponding circulating tumor cells in advanced breast cancer patientsMarta Pestrin, Silvia Bessi, Francesca Galardi, et al.Future Oncology (London, England)|April 25, 2022
A phase III trial of alpelisib + trastuzumab ± fulvestrant versus trastuzumab + chemotherapy in HER2+ PIK3CA-mutated breast cancerJose Alejandro Pérez-Fidalgo, Carmen Criscitiello, Eva Carrasco, et al.Pageof 18